Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis

Postoperative Complications and Mortality Following Colectomy for Ulcerative Colitis

(2011) Shanika de Silva et al.   Clinical Gastroenterology and Hepatology

Does Anti-TNF Therapy Reduce the Requirement for Surgery in Ulcerative Colitis? A Systematic Review

(2011) Jerome Filippi et al.   CURRENT DRUG TARGETS

Surgery for adult Crohn's disease: what is the actual risk?

(2011) G. Bouguen et al.   GUT

Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease

(2011) L. Peyrin-Biroulet et al.   GUT

Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics

(2011) Nicolas Williet et al.   INFLAMMATORY BOWEL DISEASES

Infliximab Does Not Affect Postoperative Complication Rates in Crohnʼs Patients Undergoing Abdominal Surgery

(2011) Michael S. Kasparek et al.   INFLAMMATORY BOWEL DISEASES

Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience

(2011) Gianluca Rizzo et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Infliximab and complications after colectomy in patients with ulcerative colitis

(2011) David Bregnbak et al.   Journal of Crohns & Colitis

Preoperative Infliximab is not Associated with an Increased Risk of Short-Term Postoperative Complications After Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis

(2011) Melanie L. Gainsbury et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Factors Associated With Septic Complications After Restorative Proctocolectomy

(2010) Ravi P. Kiran et al.   ANNALS OF SURGERY

Short-term outcome of infliximab and other medications on patients with inflammatory bowel disease undergoing ileostomy reversal

(2010) F. S. P. Regadas et al.   Colorectal Disease

Surgical resection in Crohn’s disease: is immunosuppressive medication associated with higher postoperative infection rates?

(2010) J. Canedo et al.   Colorectal Disease

Perioperative complications in inflammatory bowel disease

(2010) David Beddy et al.   INFLAMMATORY BOWEL DISEASES

Perioperative Anti-Tumor Necrosis Factor Therapy Does Not Increase the Rate of Early Postoperative Complications in Crohn’s Disease

(2010) Basil S. Nasir et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Preoperative infliximab treatment and postoperative complications after laparoscopic restorative proctocolectomy with ileal pouch–anal anastomosis: a case-matched study

(2010) Benjamin Coquet-Reinier et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis

(2009) Z. YANG et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis

(2009) M. Ferrante et al.   INFLAMMATORY BOWEL DISEASES

Small bowel resection rates in Crohnʼs disease and the indication for surgery over time: Experience from a large tertiary care center

(2009) Mark Lazarev et al.   INFLAMMATORY BOWEL DISEASES

Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery

(2009) Liliana Bordeianou et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Effect of Perioperative Immunosuppressive Medication on Early Outcome in Crohn’s Disease Patients

(2009) Adrian A. Indar et al.   WORLD JOURNAL OF SURGERY

Preoperative Steroid Use and Risk of Postoperative Complications in Patients With Inflammatory Bowel Disease Undergoing Abdominal Surgery

(2008) Venkataraman Subramanian et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Infliximab in Ulcerative Colitis is Associated with an Increased Risk of Postoperative Complications After Restorative Proctocolectomy

(2008) I. J. Mor et al.   DISEASES OF THE COLON & RECTUM

Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications

(2008) Hiroko Kunitake et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients

(2008) Kweku A. Appau et al.   JOURNAL OF GASTROINTESTINAL SURGERY